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Summary
Access to online repositories for genomic and associated “-omics” datasets is now an essential part
of everyday research activity. It is important therefore that the Tuberculosis community is aware
of the databases and tools available to them online, as well as for the database hosts to know what
the needs of the research community are. One of the goals of the Tuberculosis Annotation
Jamboree, held in Washington DC on March 7th–8th 2012, was therefore to provide an overview
of the current status of three key Tuberculosis resources, TubercuList (tuberculist.epfl.ch), TB
Database (www.tbdb.org), and Pathosystems Resource Integration Center (PATRIC,
www.patricbrc.org). Here we summarize some key updates and upcoming features in TubercuList,
and provide an overview of the PATRIC site and its online tools for pathogen RNA-Seq analysis.
1. Introduction
Bacterial genomes can now be sequenced in a matter of days for a few hundred dollars.
Genomic, transcriptomic, and associated data-sets are becoming so large that the extent to
which we provide user-friendly access will determine how much the Tuberculosis (TB)
research community can learn from them. The TB community therefore needs to take stock
of how we are placed to best exploit this data, and how we will deal with issues such as data
analysis, curation and dissemination.
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Web-accessible databases and analysis tools are an essential part of how we interpret and
interact with genome data; as a community we need to be kept up to date with developments
in these areas. This was one of the key aims of the TB Annotation Jamboree held in
Washington on March 7th–8th 2012, where a session was devoted to databases and related
issues. We focused our discussions on three of the key resources for TB genome data on the
web, namely TubercuList (tuberculist.epfl.ch), TB Database (www.tbdb.org), and
Pathosystems Resource Integration Center (PATRIC, www.patricbrc.org). The goal of this
manuscript is to update and introduce the community to developments in TubercuList and
PATRIC, as detailed below. Web-links to the databases and tools mentioned in this article
can be found in supplemental table 1.
2. TubercuList
2. a. Overview
TubercuList (tuberculist.epfl.ch) is a relational database for the genome sequence annotation
of Mycobacterium tuberculosis H37Rv, the reference strain commonly used in the study of
TB. This infectious disease continues to be a serious global health issue, killing 1.4 million
people in 20101. The database is a well-established resource, having been maintained since
its inception in 19982. It is a gene-centric database, and in its current form provides
information on annotated M. tuberculosis H37Rv genes and proteins, including functional
annotation, orthologous genes in closely related species, gene ontology terms, structural
information, and cross-references to several external resources including the TB Drug
Resistance Mutation Database, a comprehensive list of polymorphisms associated with drug
resistance3, and The TDR Targets Database, designed to facilitate the prioritization of drug
targets4.
One of the greatest strengths of the TubercuList database lies in the fact that it has been
subject to continuous manual annotation since the first release of the genome sequence and
annotation5, 6. It is updated with experimental evidence from the scientific literature
resulting in changes to gene boundaries, addition of new genes both protein- and RNA-
encoding, improvements in functional annotation, and assignment or modification of gene
names. This is enriched with data on the characterization of mutant strains, protein
localization determined by proteomics studies, gene essentiality under different growth
conditions, gene regulatory information, and operon structure. Citations are also provided
for all such manually selected publications from which data has been extracted.
With advances in next-generation sequencing technologies and decreasing costs, the number
of genome projects is increasing at a remarkable rate. According to the Genomes OnLine
Database, there were 11472 genome sequencing projects as of September 2011, with 2907
complete7. Although these numbers are impressive, for the majority of newly sequenced
genomes, the annotation will not go beyond computer-generated predictions8, 9. Moreover,
vast amounts of empirical data are constantly being produced at the bench, particularly from
high-throughput and genome-wide studies, and it is critical to extract key findings and apply
them to the genome annotation so that it is readily accessible in a useful form for the entire
research community. It is through this challenging task of manual annotation from the
literature, collecting and organizing data from disparate sources, that we strive to extend the
value of TubercuList for TB researchers as a current and reliable resource.
Through a partnership between the École Polytechnique Fédérale de Lausanne (EPFL) and
the SIB Swiss Institute of Bioinformatics (SIB), updating of the TubercuList database is
now carried out by the SIB who, together with the European Bioinformatics Institute (EBI)
and the Protein Information Resource (PIR), form the UniProt consortium and produce the
Swiss-Prot section of the UniProt Knowledgebase (UniProtKB/Swiss-Prot). UniProtKB/
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Swiss-Prot is an expertly curated database for protein information and M. tuberculosis is one
of several model organisms on which the database focuses (www.uniprot.org)10. Annotation
carried out by curators for UniProtKB/Swiss-Prot and for TubercuList is exchanged thereby
maximizing the results of manual annotation efforts made by both groups.
As improvements, modifications, and the incorporation of new data to the M. tuberculosis
H37Rv genome annotation are continually being made in TubercuList, we describe in the
following sections some of the recent changes that have been made and the updates that will
appear in the next release of the database (R26).
2. b. Updates to TubercuList annotation, Release 25
The TubercuList database is updated approximately every four months with information
from the literature as well as with new or updated cross-references to external databases.
The number of genes annotated in the current release of the database, version R25
completed in April 2012, has not changed significantly, now at 4095, and the coordinates of
only four coding sequences (CDS) have been altered. New genes added since version R20
from June 20106 include four CDS, one of which is a replacement for rv0061, now
annotated in the opposite orientation as rv0061c as indicated by RNA-Seq data11, 12
(Uplekar et al., in preparation). Continuing with the trend reported previously6, new CDS
added to the annotation are typically small, being less than or close to 100 amino acids. Also
added are two non-coding RNAs, regulatory molecules that are a topic of increasing
interest13, 14. There are now a total of 23 such small RNA genes annotated in TubercuList.
Advances in mass spectrometry-based proteomic methods are providing the ability to
identify wider ranges of proteins, reliably and accurately15–17. In TubercuList, 2828 proteins
are annotated as having been identified in a proteomics study, 1114 more than in the R20
version of the database. This validates 70% of protein-coding features annotated in the
genome, although a recent study, whose results await addition to the database, reports a
higher ~80% coverage of the predicted genes18. Of the 2828 proteins, 23% are categorized
as 8-Unknown or 10-Conserved hypothetical proteins, verifying that these predicted CDS
are actual proteins produced by the bacterium.
The current distribution of all M. tuberculosis H37Rv genes across eleven functional
categories is shown in Table 1. The function of one quarter (1048) of annotated CDS
remains unknown, although this number is steadily being reduced as more proteins are
characterized. Changes have been made to the functional category of 55 CDS (See Table 1)
and approximately half of these changes move CDS from 10-Conserved hypothetical
proteins to involvement in 1-Lipid metabolism. In addition to this functional annotation, 85
gene names have been added or modified, and more than half of these concern toxin-
antitoxin genes, mainly for vapBC gene pairs.
Structural biology plays an important role in understanding the mechanisms of protein
function as well as in predicting functions for unknown proteins, and can also make a
significant contribution to drug development19. TubercuList now links to 1019 structures in
the Protein Data Bank (www.pdb.org), representing 365 unique proteins. This is a
significant achievement in the field of TB research. However, as the protein structures of
most of the CDS annotated in the genome remain unknown, protein structure prediction
methods are a necessary tool to be used where experimental structure determination has not
yet succeeded20 (see Mao et al., this issue).
In this period, we have also added information on gene regulation involving eight regulatory
proteins21–29; 544 genes now have annotation on regulation. This includes data on predicted
and confirmed regulons, identification of DNA-binding motifs as well as demonstration of
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DNA-binding by the regulatory proteins, and changes in expression levels in the absence or
overexpression of the regulatory protein. Experimental evidence of operon structure has also
been added for 38 genes.
TubercuList contains references to 1285 publications. In the last five updates of the
database, 181 publications served as sources for the annotation changes described above and
were selected through searches in PubMed (www.ncbi.nlm.nih.gov/pubmed) or were
indicated by communication with the scientific community (email: tuberculist@epfl.ch).
2. c. Upcoming changes to TubercuList annotation (R26)
At the time of writing, we are in the process of preparing the next release of the TubercuList
database. For the next version of the annotation, eleven new protein-coding genes have been
added. All are proteins of unknown function with the exception of one which is a possible
PemK-like mRNA interferase. Many of these are already included in the annotation of the
CDC1551 strain of M. tuberculosis, however there is now experimental data indicating their
presence in the H37Rv strain. Their transcription is supported by RNA-Seq gene expression
data and peptides from these proteins have been identified in large-scale proteomics
studies18, 30 (Uplekar et al., in preparation). Note that novel genes indicated by large-scale
studies have been considered only when more than one source of evidence is available.
Seven non-coding regulatory RNAs will also be added to the annotation31, 32 (Uplekar et al.,
in preparation). Currently, these non-coding RNAs are named in the way referred to in the
publications reporting their discovery, however, the naming convention described by
Lamichhane and colleagues in this issue, an outcome of the TB Annotation Jamboree, will
be incorporated into the database when available. Likewise, new functional annotation that
resulted from the jamboree will soon be included in TubercuList where appropriate.
Beyond contributing to the annotation of new genes, described above, proteomics data is a
powerful tool that can be used to validate and correct existing annotation. For example
rv0157A will no longer be described as a pseudogene since peptides from its protein product
have been identified in cellular fractions of M. tuberculosis H37Rv30. In addition,
expression of rv0157A has been measured by RNA-Seq (Uplekar et al., in preparation).
There are also studies reporting hundreds of confirmed protein translation start sites, as well
as the correction of gene coordinates for a small subset of these proteins18, 30 (Uplekar et al.,
in preparation). These changes are still to be addressed and incorporated into the
TubercuList annotation. Furthermore, proteomic studies have already been used in
identifying sites of post-translational modifications of mycobacterial proteins, and continued
refinement and development of proteomic methodologies are expected to lead to greater use
of proteomics in addressing increasingly complex issues, such as the molecular mechanisms
of specific steps of the host infection process15, 16, 33, 34. It is evident that proteomic data
will continue to have an important role in improving the M. tuberculosis genome annotation
and this will be both completed and complemented by RNA-Seq analysis.
As mentioned above, approximately 25% of M. tuberculosis H37Rv CDS in TubercuList
encode proteins of unknown function. As such, since experimental data for such proteins are
lacking, predictions based on in-depth bioinformatic and computational analyses may be of
immense value with regards to hypothesis generation and testing. In an effort to address this,
the upcoming annotation will include the results of functional predictions for 652 such
proteins, based on functional interaction networks35. From this analysis, 47 6-PE/PPE and
605 10-Conserved hypothetical proteins can be re-classified into a more informative
functional category. Nearly half of these are predicted to be involved in 7-Intermediary
metabolism and respiration, while another quarter may be involved in 3-Cell wall and cell
processes.
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As many advances have been made in DNA sequencing technologies, and as more M.
tuberculosis genomes have been sequenced, errors in the H37Rv reference genome sequence
have been detected36, 37 (Uplekar et al., in preparation). Thus far, thirty-three single
nucleotide substitutions have been made to the genome sequence for database version R26,
affecting the amino acid sequence for fourteen CDS. Only those changes common to the
different datasets have been considered. These sequence corrections, in addition to the
annotation in TubercuList, are in the process of being submitted to EMBL-EBI
(www.ebi.ac.uk) as an update to the M. tuberculosis H37Rv genome sequence entry
(AL123456).
3. Pathogen Portal and PATRIC
3. a. Introduction
The Pathosystems Resource Integration Center (PATRIC, www.patricbrc.org)38 is a web-
based information system designed to support basic and applied biomedical research on
bacterial infectious diseases. It integrates genome-scale data, metadata, and analysis tools
for all bacterial pathogens and all bacteria. Together with the Virus Pathogen Resource
(ViPR, www.viprbrc.org), the Eukaryotic Pathogen Database Resources (EuPathDB,
www.eupathdb.org), VectorBase (www.vectorbase.org for invertebrate vectors of human
pathogens), and the Influenza Research Database (IRD, www.fludb.org), it represents the
five Bioinformatics Resource Centers (BRCs) funded by the National Institute of Allergy
and Infectious Diseases (NIAID). All five BRCs are connected by a common informatics
coordination center, the Pathogen Portal (www.pathogenportal.org), which provides tools
that can be utilized by all BRCs (for example RNA-Seq analyses) and consolidates
information across the individual BRCs and other NIAID-funded “big data” resource
centers.
PATRIC focuses on NIAID Category A–C bacterial pathogens, which include
Mycobacterium tuberculosis, but provides data, tools and analysis services for all publicly
available bacterial genomes. As of October 2012, PATRIC has released the genomic data for
total of 6642 bacterial genomes including 175 mycobacterial genomes (Table 2). To enable
comprehensive comparative analyses, genome annotation in PATRIC is performed in a
standardized manner using the RAST (Rapid Annotation using Subsystem Technology)
system39. PATRIC also provides a free end-user genome annotation service through RAST
to allow users to annotate their own genomes (www.patricbrc.org/portal/portal/patric/
RAST). In addition to the RAST annotations, PATRIC includes other reference annotations
(e.g., the annotation and nomenclature introduced by Cole et al. for M. tuberculosis
H37Rv2) and an Identifier (ID) Mapping tool, which allows users to quickly map between
PATRIC annotation identifiers and identifiers used by various resources, such as PDB,
RefSeq, etc. PATRIC also supports comparative analysis across multiple genomes using
protein families and metabolic pathways. Furthermore, PATRIC’s Disease View integrates
infectious disease, host, pathogen and disease outbreak data, which enables infectious
disease-centric access and analysis of host-pathogen interactions40 (enews.patricbrc.org/
faqs/virulence-and-disease-faqs). Users of PATRIC can register and create their own user-
accounts in PATRIC to save, manage and analyze the data groups gathered from the
PATRIC site to their PATRIC personal workspace (enews.patricbrc.org/faqs/workspace-
faqs). Specific workflows supporting various types of analyses have also been recently
released in PATRIC and enable finding genomic islands, identifying proteins from outbreak
strains, and comparing diverse biochemical pathways, for example. Increasing functionality
and improved workflows are being developed through the private, personal PATRIC
workspace, to support infectious disease researchers in the process of uploading their own
data for analysis with collaborators, generating results and figures for publications,
presentations and grant applications, and, ultimately, releasing the results to the broader
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scientific community. A detailed description of PATRIC has recently been published38, 40.
Here, we provide an update on the specific data, tools and services that PATRIC provides
for the analysis of bacterial gene expression, which have been released after the Gillespie et
al. (2011) publication.
3. b. RNA-Seq analysis pipeline at Pathogen Portal
Pathogen Portal (www.pathogenportal.org) is focused scientifically on enabling comparative
analysis of host response to pathogens, while using its infrastructure to provide common
services across BRCs when appropriate. For example, the Pathogen Portal provides an
RNA-Seq pipeline for processing and analyzing high throughput sequencing data to
characterize the transcriptome of all BRC pathogens and their key hosts. As the Pathogen
Portal is part of the BRC program, it can be used to analyze transcriptome data for the
thousands of genomes stored at PATRIC, VectorBase, and EuPathDB. The pipeline is built
on Galaxy, an open source bioinformatics workflow system infrastructure41. The Galaxy
system has been modified by the Pathogen Portal team to help simplify the process of RNA-
Seq analysis for routine use by informatics-naïve, biologically focused users and provide a
guided experience to quality control of read data, read mapping, assembling transcripts,
estimating gene expression values, and doing differential expression analysis (Figure 1). As
of October 2012, the Portal’s RNA-Seq pipeline had 175 Mycobacterial genomes, of which
74 were M. tuberculosis. Genomes for use as references by the RNA-Seq pipeline are
frequently updated as new sequences are published at PATRIC, VectorBase, or EuPathDB.
Researchers can upload read data into their own private project space at the Pathogen Portal
and use the system to contrast expression profiles for various states of Mycobacterium spp.
The resulting data can also be used to discover new genes and alternative start transcription
sites, for example. The pipeline records provenance information, including the tools and
parameters used to process the data, supports batch analysis for multiple samples, and
provides secure results sharing and publishing. The RNA-Seq Pipeline is available at
rnaseq.pathogenportal.org and is free to use.
3. c. Expression data at PATRIC
PATRIC provides a suite of integrated methods and tools to explore, visualize, analyze, and
compare a large number of published gene expression data-sets available at PATRIC as well
as upload and analyze their own unpublished gene expression data-sets, including RNA-Seq
data. PATRIC has incorporated a large number of published gene expression data-sets
related to bacterial pathogens from NCBI’s GEO database (www.ncbi.nlm.nih.gov/geo).
Once a data-set is retrieved from GEO, it is curated by carefully reviewing and curating
published experimental design and protocol. Organism and gene identifiers described in the
expression array platform are mapped to corresponding genomes and genes in PATRIC.
Data from replicates are merged, normalized and log-transformed using a manual curation
process for quality control. Experimental procedures and sample metadata are also curated
to accurately and consistently capture information such as sample strain, genetic
modification, experimental condition, treatment, and time-point. Then, the expression data
are combined with the other genomic data in PATRIC to provide integrated data analysis
capabilities. As of October 2012, PATRIC has incorporated Mycobacterium-related gene
expression data from 45 published data-sets, which correspond to 549 curated comparisons.
PATRIC also allows researchers to upload unpublished gene expression data into their free
private workspace to explore them with various analysis and visualization tools (further
described below) and to compare them with the public data-sets at PATRIC. Pre-processed
gene expression data generated by using either microarray or high-throughput sequencing
technologies can be uploaded to PATRIC as excel or tab-delimited files in the form of a
gene list or a gene matrix. An additional file containing sample metadata is also provided to
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aid in the data analysis. These file formats are further described at enews.patricbrc.org/faqs/
transcriptomics-data-faqs/. Transcriptomics data generated using high-throughput
sequencing technologies can first be processed using the RNA-Seq analysis pipeline
available at Pathogen Portal and then be imported to the PATRIC workspace for further
analysis (Figure 1). Some of the expression data-related tools and functionality available on
the PATRIC website are described below.
3. c.1 Experiment and sample list—For any taxonomy level or genome, all publicly
available data-sets are displayed as experiment and sample lists. Metadata-based searching
and progressive filtering allows researchers to quickly find data-sets of interest. For each of
the samples, numbers of differentially expressed genes identified to be significant (|log ratio
≥ 1 or |Z-score| ≥ 2) are summarized and linked to the corresponding gene list. Multiple
data-sets can be selected for further analysis across multiple experiments and/or can be
saved as a group for repeated or future use.
3. c.2 Gene list based on expression data—PATRIC researchers can create a gene
list based on the expression data-sets of their interest, which displays all the genes reported
in the selected data-sets, their functions, and summarizes their expression levels. Gene lists
can be dynamically filtered to find the most differentially expressed genes by applying
different log ratio and/or Z-score thresholds. Lists can also be filtered by gene names or
functions to analyze expression of any genes of interest. Researchers also can find genes that
are up- or down-regulated in only a subset of samples of interest. Once a subset of genes of
interest are found, they can be downloaded, along with their annotations and expression
values, as a tab-delimited or Excel file or they can be saved as a group for further analysis.
The pathway summary tool (enews.patricbrc.org/faqs/transcriptomics-data-faqs) allows
researchers to quickly find top metabolic pathways corresponding to their genes of interest
and visualize them in KEGG42 (Kyoto Encyclopedia of Genes and Genomes) maps along
with all other genes annotated in a pathway.
3. c.3 Heatmap visualization and clustering—Complementary to the gene list is the
2-D visualization or “heatmap tool” that shows expression levels of all the genes in a gene
list across all selected samples. Genes displayed in the heatmap can be filtered and
researchers can switch between the gene list and the heatmap view at any point. Genes in the
heatmap can be sorted based on their genomic locations to visually detect genomic regions
that are similarly or differently expressed across multiple samples. Genes and samples can
also be sorted by applying hierarchical clustering, which allows researchers to quickly
identify group of genes that are similarly expressed across multiple samples. Any area of the
heatmap can be selected to download corresponding expression data or to save the genes as
a group.
3. c.4 Sample metadata analysis—For a given gene, top samples in which the gene
expression passes the specified threshold are listed along with their metadata, such as
sample strain, genetic modification, and experimental conditions. A visual summary of the
metadata allows researchers to find top experimental conditions and gene manipulations that
a gene responds to and confirm or infer potential function of the gene.
3. c.5 Genes with correlated expression—For a gene of interest, lists of genes with
the most highly correlated expression profiles (positively or negatively) across all publicly
available data-sets are displayed along with their function. This allows researchers to
identify potentially co-regulated genes or genes that perform similar functions and, often,
generate hypothesis about potential function of a hypothetical gene.
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4. Conclusions
Access to high quality genome annotation and analysis tools is essential for a modern
research community, and we are well served in this regard by the TubercuList and PATRIC
resources outlined above. Just some of the information and tools that are available in
TubercuList and PATRIC have been presented here, highlighting the increasing
sophistication of resources that are available to users. To further tailor these resources to the
needs of the community we look forward to getting feedback for TubercuList (email:
tuberculist@epfl.ch) and PATRIC (email: patric@vbi.vt.edu).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
RNA-Seq analysis workflow in Pathogen Portal and PATRIC.
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Table 1
Distribution of genes across functional categories (TubercuList version R25)
Functional Category Gene number Change from R20
0 Virulence, detoxification, adaptations 238 10
1 Lipid metabolism 272 25
2 Information pathways 242 1
3 Cell wall and cell processes 773 -
4 Stable RNAs 73 2
5 Insertion sequences and phages 147 -
6 PE/PPE 168 -
7 Intermediary metabolism and respiration 936 13
8 Unknown 16 -
9 Regulatory proteins 198 3
10 Conserved hypothetical proteins 1032 −49
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Table 2
Number of genomes available at PATRIC (as of October 2012).
All bacteria Mycobacterium spp.
Number of genomes 6642 175
Number of complete genomes 1927 43
Number of incomplete genomes 4713 132
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